PIONEER REAL Japan: Primary results from a multicenter, prospective, real‐world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice.

Autor: Yabe, Daisuke1,2,3,4 (AUTHOR) ydaisuke@kuhp.kyoto-u.ac.jp, Hamamoto, Yoshiyuki4,5 (AUTHOR), Kawanami, Daiji6 (AUTHOR), Nishimura, Rimei7 (AUTHOR), Terauchi, Yasuo8 (AUTHOR), Amadid, Hanan9 (AUTHOR), Braae, Uffe Christian10 (AUTHOR), Major‐Pedersen, Atheline11 (AUTHOR), Suzuki, Ryo12 (AUTHOR)
Zdroj: Journal of Diabetes Investigation. Nov2024, Vol. 15 Issue 11, p1566-1577. 12p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje